Yttrium-90 microspheres for the treatment of hepatocellular carcinoma

El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001 American Cancer Society. Cancer facts & figures 2002. Cancer: basic facts—estimated new cancer cases and deaths by gender, US, 2002. Available at: http://www.cancer.org/downloads/stt/cancerfacts&figures2002tm.pdf. Choti, 2002, Surgical management of hepatocellular carcinoma, J Vasc Interv Radiol, 13, S197, 10.1016/S1051-0443(07)61787-4 Patt, 2002, Role of liver transplantation in the management of hepatocellular carcinoma, J Vasc Interv Radiol, 13, S205, 10.1016/S1051-0443(07)61788-6 El-Serag, 2001, Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States, Hepatology, 33, 62, 10.1053/jhep.2001.21041 Ahmed, 2002, Thermal ablation therapy for hepatocellular carcinoma, J Vasc Interv Radiol, 13, S231, 10.1016/S1051-0443(07)61791-6 Ramsey, 2002, Chemoembolization of hepatocellular carcinoma, J Vasc Interv Radiol, 13, S211, 10.1016/S1051-0443(07)61789-8 Leung, 2001, Determinants of postembolization syndrome after hepatic chemoembolization, J Vasc Interv Radiol, 12, 321, 10.1016/S1051-0443(07)61911-3 1995, A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma, N Engl J Med, 332, 1256, 10.1056/NEJM199505113321903 Ingold, 1965, Radiation hepatitis, Am J Roentgenol Radium Ther Nucl Med, 93, 200 Fajardo, 1980, Pathogenesis of veno-occlusive liver disease after radiation, Arch Pathol Lab Med, 104, 584 Lewin, 1973, Human radiation hepatitis, Arch Pathol, 96, 21 Minsky, 1989, The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole, Cancer Treat Rev, 16, 213, 10.1016/0305-7372(89)90042-X Dawson, 2002, Analysis of radiation-induced liver disease using the Lyman NTCP model, Int J Radiat Oncol Biol Phys, 53, 810, 10.1016/S0360-3016(02)02846-8 Robertson, 1997, Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers, Int J Radial Oncol Biol Phys, 37, 325, 10.1016/S0360-3016(96)00528-7 McGinn, 1998, Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model, J Clin Oncol, 16, 2246, 10.1200/JCO.1998.16.6.2246 Russell, 1988, Dosimetry calculations for yttrium-90 used in the treatment of liver cancer, Endocuriether Hypertherm Oncol, 4, 171 Dancey, 2000, Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres, J Nucl Med, 41, 1673 Salem, 2002, Yttrium-90 microspheres, J Vasc Interv Radiol, 13, S223, 10.1016/S1051-0443(07)61790-4 Synder, 1976 Child, 1964, Surgery and portal hypertension, 1950 Pugh, 1973, Transection of the oesophagus for bleeding oesophageal varices, Br J Surg, 60, 646, 10.1002/bjs.1800600817 Okuda, 1985, Natural history of hepatocellular carcinoma and prognosis in relation to treatment, Cancer, 56, 918, 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E 1998, A new prognostic system for hepatocellular carcinoma, Hepatology, 28, 751, 10.1002/hep.510280322 2000, Prospective validation of the CLIP score, Hepatology, 31, 840, 10.1053/he.2000.5628 Levy, 2002, Staging of hepatocellular carcinoma, Gut, 50, 881, 10.1136/gut.50.6.881 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Cox, 1984 Carr, 2002, Hepatic artery chemoembolization for advanced stage HCC, Hepatogastroenterology, 49, 79 Rilling, 2002, Multidisciplinary management of hepatocellular carcinoma, J Vasc Interv Radiol, 13, 5259, 10.1016/S1051-0443(07)61794-1 Salem, 2004, Use of yttrium-90 glass microspheres (TheraSphere®) for the treatment of unresectable hepatocellular carcinoma (HCC) in patients with portal vein thrombosis, J Vasc Interv Radiol, 15, 335, 10.1097/01.RVI.0000123319.20705.92 Kanematsu, 2003, Hepatocellular carcinoma of diffuse type, J Magn Reson Imaging, 18, 189, 10.1002/jmri.10336 Lee, 1997, The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction, Cancer, 79, 2087, 10.1002/(SICI)1097-0142(19970601)79:11<2087::AID-CNCR5>3.0.CO;2-M Lopez, 2002, Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma, Arch Surg, 137, 653, 10.1001/archsurg.137.6.653 Raoul, 1994, Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis, J Nucl Med, 35, 1782 de Baere, 1999, Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow, Radiology, 212, 665, 10.1148/radiology.212.3.r99se03665 Ramsey, 2002, Chemoembolization of hepatocellular carcinoma—what to tell the skeptics, Tech Vasc Interv Radiol, 5, 122, 10.1053/tvir.2002.36418 Geschwind, 2003, Chemoembolization of hepatocellular carcinoma, Am J Clin Oncol, 26, 344, 10.1097/01.COC.0000020588.20717.BB Lo, 2002, Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma, Hepatology, 35, 1164, 10.1053/jhep.2002.33156 Llovet, 2002, Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma, Lancet, 359, 1734, 10.1016/S0140-6736(02)08649-X Raoul, 1997, Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma, Hepatology, 26, 1156 Henderson, 2003, AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma, HPB, 5, 243, 10.1080/13651820310015833 Di Bisceglie, 2004, A common staging system for hepatocellular carcinoma, Hepatology, 39, 550, 10.1002/hep.20072 Bruix, 2004, Prognostic prediction in HCC, Hepatology, 39, 551, 10.1002/hep.20050 Columbo, 2004, The strategic role of staging in the treatment of HCC, Hepatology, 39, 552, 10.1002/hep.20112 Goin, 2004, Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma, World J Nucl Med, 3, 49 Bruix, 2001, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, J Hepatol, 35, 421, 10.1016/S0168-8278(01)00130-1 Steel, 2004, Quality of life in patients diagnosed with primary hepatocellular carcinoma, Psychooncology, 13, 73, 10.1002/pon.725